Kitov Pharmaceuticals’ Investigation by the Israeli Security Authority on Suspicion of Fraud and False Reporting

the Litigation Department at Barnea & Co. represented the CEO of Kitov Pharmaceuticals at a hearing in the Tel Aviv Magistrates Court relating to his release from detention, subject to certain restrictive conditions.

Kitov Pharmaceuticals Holdings Ltd., through its subsidiary, Kitov Pharmaceuticals Ltd., operates as a clinical development stage biopharmaceutical company. The company, led by Isaac Israel, John Paul Waymack and Simcha Rock, is based in Tel Aviv.

Barnea & Co. has advised Isaac Israel with a team including Zohar Lande (Picture) and Moran Bickel.

Involved fees earner: Zohar Lande – Barnea & Co.; Moran Bickel – Barnea & Co.;

Law Firms: Barnea & Co.;

Clients: Isaac Israel;


Author: Michael Patrini.